• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

醛固酮对正常血压肾脏的直接成纤维作用:11β-HSD 活性对其的影响。

Direct fibrogenic effects of aldosterone on normotensive kidney: an effect modified by 11β-HSD activity.

机构信息

Div. of Kidney Diseases and Hypertension, Rhode Island Hospital, Providence, RI 02903, USA.

出版信息

Am J Physiol Renal Physiol. 2010 May;298(5):F1178-87. doi: 10.1152/ajprenal.00532.2009. Epub 2010 Mar 3.

DOI:10.1152/ajprenal.00532.2009
PMID:20200098
Abstract

Aldosterone (Aldo) can be a profibrotic factor in cardiovascular and renal tissues. This study tests the hypothesis that prolonged Aldo exposure is able to directly induce fibrotic changes in the kidney of a normal nonhypertensive animal. Immortalized rat proximal tubule cells (IRPTC) containing 11β-hydroxysteroid dehydrogenase (11β-HSD1) but no mineralocorticoid receptors (MR) and mouse inner medullary collecting duct cells (IMCD) containing 11β-HSD2 and MR were examined. IRPTC exposed to Aldo or corticosterone (10 nM) for 48 h demonstrated no change in collagen production as assessed by Sirius red staining. In contrast, IMCD treated with Aldo exhibited a marked increase in the expression of collagen, fibronectin, and connective tissue growth factor (CTGF), whereas corticosterone alone had no effect. The Aldo-induced overexperession of collagen, fibronectin, and CTGF was substantially attenuated by the MR antagonist RU-318 and by the 11β-HSD end product 11-dehydrocorticosterone, but not by the glucocorticoid receptor antagonist RU-486. In vivo, early fibrotic changes with elevated collagen, fibronectin, and CTGF expression were observed in kidneys isolated from normotensive adrenalectomized mice receiving a continuous infusion of Aldo (8 μg·kg(-1)·day(-1)) for 1 wk. These changes were not present in corticosterone-treated mice. Aldo-induced changes were attenuated in adrenally intact mice and in mice treated with RU-318 or 11-dehydrocorticosterone. Thus, extended Aldo exposure produces fibrotic changes in cells containing MR and in normal kidneys. MR antagonists and the end products of 11β-HSD attenuate these fibrogenic effects.

摘要

醛固酮(Aldo)可作为心血管和肾脏组织的致纤维增生因子。本研究检验了这样一个假说,即延长 Aldo 暴露能够直接诱导正常非高血压动物肾脏中的纤维性变化。含有 11β-羟类固醇脱氢酶(11β-HSD1)但不含盐皮质激素受体(MR)的永生化大鼠近端肾小管细胞(IRPTC)和含有 11β-HSD2 和 MR 的小鼠内髓集合管细胞(IMCD)接受了检测。将 Aldo 或皮质酮(10 nM)暴露于 IRPTC 48 h 后,用 Sirius red 染色评估胶原产生没有变化。相比之下,用 Aldo 处理的 IMCD 表现出胶原、纤维连接蛋白和结缔组织生长因子(CTGF)的表达显著增加,而单独的皮质酮没有影响。MR 拮抗剂 RU-318 和 11β-HSD 终产物 11-脱氧皮质酮显著减弱了 Aldo 诱导的胶原、纤维连接蛋白和 CTGF 的过度表达,但糖皮质激素受体拮抗剂 RU-486 没有作用。在体内,从接受连续 Aldo(8 μg·kg(-1)·day(-1))输注 1 周的正常去肾上腺小鼠分离的肾脏中观察到早期纤维化变化,伴有胶原、纤维连接蛋白和 CTGF 表达升高。在皮质酮处理的小鼠中没有观察到这些变化。Aldo 诱导的变化在肾上腺完整的小鼠中和在用 RU-318 或 11-脱氧皮质酮处理的小鼠中减弱。因此,延长的 Aldo 暴露会导致含有 MR 的细胞和正常肾脏发生纤维性变化。MR 拮抗剂和 11β-HSD 的终产物减弱了这些纤维生成作用。

相似文献

1
Direct fibrogenic effects of aldosterone on normotensive kidney: an effect modified by 11β-HSD activity.醛固酮对正常血压肾脏的直接成纤维作用:11β-HSD 活性对其的影响。
Am J Physiol Renal Physiol. 2010 May;298(5):F1178-87. doi: 10.1152/ajprenal.00532.2009. Epub 2010 Mar 3.
2
In vivo nuclear translocation of mineralocorticoid and glucocorticoid receptors in rat kidney: differential effect of corticosteroids along the distal tubule.糖皮质激素受体和盐皮质激素受体在大鼠肾脏中的核内易位:糖皮质激素沿远端肾小管的差异效应。
Am J Physiol Renal Physiol. 2010 Dec;299(6):F1473-85. doi: 10.1152/ajprenal.00437.2010. Epub 2010 Sep 22.
3
Adrenalectomy amplifies aldosterone induced injury in cardiovascular tissue: an effect attenuated by adrenally derived steroids.肾上腺切除术增强了醛固酮引起的心血管组织损伤:这种效应可被肾上腺源性类固醇减弱。
Steroids. 2013 Mar;78(3):347-55. doi: 10.1016/j.steroids.2012.12.007. Epub 2012 Dec 31.
4
Dexamethasone enhances basal and TNF-alpha-stimulated production of PAI-1 via the glucocorticoid receptor regardless of 11beta-hydroxysteroid dehydrogenase 2 status in human proximal renal tubular cells.在人近端肾小管细胞中,无论11β-羟基类固醇脱氢酶2的状态如何,地塞米松都通过糖皮质激素受体增强纤溶酶原激活物抑制剂-1的基础分泌及肿瘤坏死因子-α刺激后的分泌。
Nephrol Dial Transplant. 2009 Jun;24(6):1759-65. doi: 10.1093/ndt/gfn756. Epub 2009 Jan 18.
5
Stimulation of testosterone production in rat Leydig cells by aldosterone is mineralocorticoid receptor mediated.醛固酮对大鼠睾丸间质细胞睾酮生成的刺激作用是由盐皮质激素受体介导的。
Mol Cell Endocrinol. 2005 Nov 24;243(1-2):35-42. doi: 10.1016/j.mce.2005.08.004. Epub 2005 Sep 26.
6
Mineralocorticoid versus glucocorticoid receptor occupancy mediating aldosterone-stimulated sodium transport in a novel renal cell line.在一种新型肾细胞系中,盐皮质激素与糖皮质激素受体占有率介导醛固酮刺激的钠转运
J Am Soc Nephrol. 2005 Apr;16(4):878-91. doi: 10.1681/ASN.2004121110. Epub 2005 Mar 2.
7
Uninephrectomy reduces 11β-hydroxysteroid dehydrogenase type 1 and type 2 concomitantly with an increase in blood pressure in rats.肾切除术可同时降低大鼠的 11β-羟类固醇脱氢酶 1 型和 2 型,同时增加血压。
J Endocrinol. 2012 Sep;214(3):373-80. doi: 10.1530/JOE-12-0200. Epub 2012 Jun 27.
8
Distribution of glucocorticoid and mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenases in human and rat ocular tissues.糖皮质激素和盐皮质激素受体以及11β-羟基类固醇脱氢酶在人和大鼠眼组织中的分布
Invest Ophthalmol Vis Sci. 2000 Jun;41(7):1629-38.
9
In vitro characterization of aldosterone and cAMP effects in mouse distal convoluted tubule cells.醛固酮和环磷酸腺苷对小鼠远曲小管细胞作用的体外特性研究
Am J Physiol Renal Physiol. 2004 May;286(5):F936-44. doi: 10.1152/ajprenal.00070.2003. Epub 2004 Mar 2.
10
In vivo inhibition of renal 11beta-hydroxysteroid dehydrogenase in the rat stimulates collecting duct sodium reabsorption.体内抑制大鼠肾脏11β-羟类固醇脱氢酶可刺激集合管对钠的重吸收。
Clin Sci (Lond). 2001 Aug;101(2):195-8.

引用本文的文献

1
Strategies to address diabetic kidney disease burden in Mexico: a narrative review by the Mexican College of Nephrologists.应对墨西哥糖尿病肾病负担的策略:墨西哥肾脏病学会的叙述性综述
Front Med (Lausanne). 2024 Jun 19;11:1376115. doi: 10.3389/fmed.2024.1376115. eCollection 2024.
2
Potential of Modulating Aldosterone Signaling and Mineralocorticoid Receptor with microRNAs to Attenuate Diabetic Kidney Disease.利用 microRNAs 调节醛固酮信号和盐皮质激素受体以减轻糖尿病肾病的潜力。
Int J Mol Sci. 2024 Jan 10;25(2):869. doi: 10.3390/ijms25020869.
3
Renal Injuries in Primary Aldosteronism: Quantitative Histopathological Analysis of 19 Patients With Primary Adosteronism.
原发性醛固酮增多症中的肾损伤:19 例原发性醛固酮增多症患者的定量组织病理学分析。
Hypertension. 2021 Aug;78(2):411-421. doi: 10.1161/HYPERTENSIONAHA.121.17436. Epub 2021 Jun 14.
4
Transtubular potassium gradient predicts kidney function impairment after adrenalectomy in primary aldosteronism.跨肾小管钾梯度可预测原发性醛固酮增多症患者肾上腺切除术后的肾功能损害。
Ther Adv Chronic Dis. 2020 Aug 27;11:2040622320944792. doi: 10.1177/2040622320944792. eCollection 2020.
5
Brain natriuretic peptide mitigates TIMP2 induction and reinstates extracellular matrix catabolic activity GSK3β inhibition in glomerular podocytes exposed to a profibrogenic milieu.脑钠肽减轻暴露于促纤维化环境中的肾小球足细胞中TIMP2的诱导并恢复细胞外基质分解代谢活性,同时抑制GSK3β。
Am J Transl Res. 2019 Feb 15;11(2):964-973. eCollection 2019.
6
Ecdysone Elicits Chronic Renal Impairment via Mineralocorticoid-Like Pathogenic Activities.蜕皮激素通过类盐皮质激素致病活性引发慢性肾损伤。
Cell Physiol Biochem. 2018;49(4):1633-1645. doi: 10.1159/000493499. Epub 2018 Sep 18.
7
Activation of mineralocorticoid receptor by ecdysone, an adaptogenic and anabolic ecdysteroid, promotes glomerular injury and proteinuria involving overactive GSK3β pathway signaling.蜕皮激素作为一种适应原和合成代谢的蜕皮甾体,通过激活其受体,促进肾小球损伤和蛋白尿,涉及过度活跃的 GSK3β 通路信号转导。
Sci Rep. 2018 Aug 15;8(1):12225. doi: 10.1038/s41598-018-29483-7.
8
miR-34c-5p and CaMKII are involved in aldosterone-induced fibrosis in kidney collecting duct cells.miR-34c-5p 和 CaMKII 参与醛固酮诱导的肾集合管细胞纤维化。
Am J Physiol Renal Physiol. 2018 Mar 1;314(3):F329-F342. doi: 10.1152/ajprenal.00358.2017. Epub 2017 Oct 25.
9
Effects of Treating Primary Aldosteronism on Renal Function.原发性醛固酮增多症的治疗对肾功能的影响。
J Clin Hypertens (Greenwich). 2017 Mar;19(3):290-295. doi: 10.1111/jch.12914. Epub 2016 Sep 23.
10
Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular disease.醛固酮的治疗靶向:一种治疗肾小球疾病的新方法。
Clin Sci (Lond). 2015 May;128(9):527-35. doi: 10.1042/CS20140432.